High KIF2C expression was associated with age, pathological stage, lymph node metastases, prostate-specific antigen (PSA), and Gleason score and significantly predicted an unfavorable prognosis in PCa patients. This evidence concerns the gene KIF2C and metastatic malignant neoplasm in the lymph nodes.